Transjugular intrahepatic portosystemic shunt (TIPS)
Sponsors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University Hospital, Tours, Air Force Military Medical University, China, Sun Yat-sen University, Argon Medical Devices
Conditions
AscitesAscites HepaticBleeding VaricesCirrhosis, LiverCirrhotic Portal HypertensionDecompensated CirrhosisEsophageal and Gastric VaricesHepatocellular Carcinoma
Phase 2
TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
RecruitingNCT05882370
Start: 2022-12-01End: 2025-08-31Target: 30Updated: 2024-10-16
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
RecruitingNCT06646198
Start: 2024-10-08End: 2026-12-31Target: 40Updated: 2024-10-17
Phase 3
Phase 4
Unknown Phase
PTFE Covered Stents Versus Naked Stents in the TIPS (Transjugular Intra-hepatic Porto-systemic Shunt)
CompletedNCT00593528
Start: 2008-02-18End: 2011-07-11Updated: 2025-12-22
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
CompletedNCT01326949
Start: 2011-05-31End: 2016-01-31Updated: 2017-05-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
NCT04640116
Start: 2021-02-01End: 2023-06-30Target: 30Updated: 2020-12-19
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
TerminatedNCT05765253
Start: 2023-07-13End: 2023-11-19Updated: 2024-12-11
Early TIPS in Patients With Liver Cirrhosis and Ascites
RecruitingNCT06576934
Start: 2025-04-01End: 2029-02-15Target: 134Updated: 2026-05-01